Efficacy, pharmacokinetics, and safety of subcutaneous C1-esterase inhibitor as prophylaxis in Japanese patients with hereditary angioedema: Results of a Phase 3 study.
Allergol Int
; 72(3): 451-457, 2023 Jul.
Article
in En
| MEDLINE
| ID: mdl-36858856
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Complement C1 Inhibitor Protein
/
Angioedemas, Hereditary
Type of study:
Clinical_trials
/
Observational_studies
Limits:
Humans
Language:
En
Journal:
Allergol Int
Journal subject:
ALERGIA E IMUNOLOGIA
Year:
2023
Type:
Article